Is Viant Technology, Inc. overvalued or undervalued?

As of 7 July 2025, the valuation grade for Viant Technology, Inc. has moved from attractive to fair. The company appears to be overvalued given its high P/E ratio of 65, a price-to-book value of 25.45, and an EV to EBITDA ratio of 33.14, which are significantly above industry norms. In comparison, peers like OptimizeRx Corp. have a P/E of 45.18 and a much lower EV to EBITDA of 20.43, indicating that Viant is trading at a premium relative to its industry.
Despite a strong ROE of 39.06%, the company's performance has been lackluster, with a year-to-date return of -50.5% compared to the S&P 500's 12.22%. This stark contrast reinforces the notion that Viant Technology, Inc. is currently overvalued in the market.